Tag Archives: advocacy

The March for Science is Futile & Performative

On April 14, the March for Science 2018 took place in the Christopher Columbus park at the waterfront. This year’s march was definitely smaller than last year, with a small crowd braving the cold winds on a cloudy day to attend a rally that focused largely on climate change. Despite my reservations of the possible outcomes of the march based on last year’s march and its complications, I attended the rally in support of what I believed to be an effective organizational method. However, I was bitterly disappointed. The March for Science, once again, proved itself to be futile and performative.

Much has been said and written, memes have been made and shared widely across social media in support of evidence-based policy and Science, and scientists have braved the ballot boxes in recent political races. All of this has been built around the mantras of “Stand Up for Science”, “I believe in Science”, and “What do we want? Peer-reviewed Evidence”. However, the core problem with these slogans is that they are effectively apolitical. And this is not even a new problem – last year’s March organizers were plagued by questions of why they had a diversity statement and public arguments that “Science” should not be politicized. Incidentally, at this year’s march, there were a few people gathered around a sign about Republicans supporting Science, enforcing the false dichotomy that Democrats as a political party are more likely to believe in scientific evidence. Furthermore, the rally seemed to have canvassers for liberal candidates running for various political offices, almost all on the Democratic party ticket, and some speakers openly advocating rally-goers to vote for specific candidates. But what was absent in the rally was a core political agenda, or any agenda for that matter, besides how bad Climate Change is getting and how the Trump administration is so evil.

Nowhere was there any mention of the environmental problems that the locale are facing, e.g. – Governor Charlie Baker’s bill that would privatize water bodies in MA, or the clean water crisis in the Norfolk state correctional facility where inmates have not had clean water for several months now. While MA is often lauded as a progressive state that promises carbon neutral buildings and other environmental regulations, in reality, that is not the case. For example, the city of Boston recently approved a pipeline that will bring in fracked natural gas from Pennsylvania to a luxury condominium complex in back bay. While there has been resistance from the MA administration against the Bureau of Ocean Energy Management’s plan to open up offshore drilling in a million acres in the Outer Continental Shelf, the language around the protest was framed in a NIMBY manner specifically for MA, as if oil spills anywhere else in the East Coast won’t be affecting the MA coast.

Without a coherent political agenda, it doesn’t mean anything to “Stand Up for Science” or to “Believe in Science.” This is mostly because while data itself can be neutral, study designs and interpretations/analysis of said data are not. As science historian Naomi Oreskes details in her book “Merchants of Doubt”, the same data has been manipulated by climate change deniers, who were scientists themselves. And the raison d’etre for these people were their political beliefs. Similarly, “peer-reviewed evidence” has been historically manipulated for profit motives, political gains and social beliefs that have resulted in the detriment of the human condition, in particular, those of the marginalized communities. In fact, the very idea of “Believing in Science” or considering that Science is apolitical elevates Science to an infallible and monolithic level, which undermines the very basis of the Scientific Method. Unfortunately, the consequences of such actions are already evident in the corruption of scientific research with a capitalist competitive model driving a rise in fraudulent publications of so-called “peer-reviewed evidence”. This capitalist motive further enhances the alienation between scientific fields, with certain fields that have direct output towards driving an imperialist capitalist machinery gaining more funding than some other fields.

In the last year or so, multiple scientists have come forward and braved the ballot boxes and continue doing so (the most recent example being Valerie Horsley from Yale who just gave a talk at Sackler to the CMDB program). And some of them seem to be winning as well. But it should take more than just being a scientist to win an election – the implicit assumption of being a scientist is that you will do the best for people. However, this utopian idea regarding scientists as only acting in the best interest of the people is quite frankly a naïve one. Yes, we should be electing more scientists into office, but we shouldn’t let that identity just be our standard. We should also be critically reviewing their political platforms and see if they are indeed, backed up by evidence and would act in the best interest of ALL people.

On April 14, the same day as the March for Science, David Buckel, a prominent LGBT rights lawyer and an environmental activist, committed suicide by self-immolation in Prospect Park, Brooklyn, NY. It was an act of resistance to convey the urgency of the impending doom of climate change, and an act of anguish that conveyed the pettiness surrounding the nuanced haggling of carbon tax and trading, strategies that are insufficient to bring forth the changes we need to reverse the tide of climate change. In order to do so, as scientists and individuals, and as part of a collective community, we need to acknowledge that Science, like any other human process, is vulnerable to political and economic motivations. Furthermore, any organized efforts to curb climate change or create evidence-based policy, should strive to have a coherent political agenda, to avoid being futile and performative.

Reflections from AAAS 2017 – Research During the Trump Administration

The theme of this year’s American Association for the Advancement of Science (AAAS) meeting in Boston was “Serving Society through Science Policy.” As we move through the first few months of a new administration, this gathering could not have been more timely. While this conference is diverse with topics ranging from gene editing to criminology, the undercurrent of the meeting was anxiety over what will happen to research under the Trump administration.

What is science policy even? Most in this audience probably think of it as how much money research gets budgeted and occasional rule changes on whether fetal stem cell research can occur. Generally, science policy is the set of federal rules and policies that guide how research is done. Science policy can be split into two general frameworks: policy for science and science for policy. These can often feed into each other. For example, policy for science provides funds for climate research. The data and conclusions derived from that research could then inform new climate related policies. That would be science for policy. While science itself is an important input into the whole process, other considerations such as economics, ethics, budgets and public opinion are also inputs. As a scientist who considers science as a method of interpreting the world, my biases had not let me consider non-science inputs for science policy decision-making. It may seem obvious to some, but it was illuminating to realize that other concerns can be just as valuable and legitimate.

As funding is a major reason scientists are concerned, I was happy to learn a lot about the place of research in the federal budget. There are some out there who believe that research in Boston will be fine no matter who is in charge because of all the industry science in the area. It’s true; around two-thirds of research and development is funded by industry. However, industry is mostly concerned with development. Basic research is primarily funded by federal money. The federal budget is divided into mandatory spending and discretionary spending. Mandatory spending does not require congress to act for programs in it to be funded. These include the entitlement programs such as Social Security, Medicare and Medicaid. Dr. Josh Shiode, a Senior Government Relations Officer from AAAS, informed us that entitlement programs are considered “third-rail” discussions by lawmakers, meaning if you touch them, you die (an electoral death). In contrast, discretionary spending requires Congress to actively fund. Most of research and development spending falls into this category.

 

 

Due to changing (aging) demographics, the percentage of the budget that goes towards mandatory spending has been steadily increasing. 50 years ago, we spent around 30% of the federal budget on mandatory spending and now we are up to 70% and increasing. Research and development generally gets around 10-12% of the remaining budget left for discretionary spending. Traditionally, increases in discretionary defense spending will correspond with a parallel increase in nondefense discretionary spending. The Trump administration has proposed increases in military spending. Given likely tax cuts and reluctance to make changes to entitlement programs, it is unlikely nondefense discretionary funding will fare well. The good news is major research programs like the BRAIN Initiative, Precision Medicine Initiative and the Cancer Moonshot were funded through the bipartisan 21st Century Cures act during the lame-duck session. While NIH and biomedical research will likely have diminished profiles during this administration, both parties are against Alzheimer’s, diabetes and cancer. What is less clear is how research performed by the EPA and Department of Agriculture will fare although initial reports are grim. Finally, repeal of the Affordable Care Act will have rippling effects, as many research universities are also providers of healthcare. It is clear that there will be a shift in culture. Under President Obama, science was elevated and scientists were regularly consulted. As former senior science adviser to President Obama John Holdren said: “Trump resists facts he doesn’t like”.

There is reluctance for some scientists to get involved in the political theater, as some believe science should be apolitical. I would argue that science is already political as science can dictate policy and policy can dictate science. What science is and should be is nonpartisan. No party has an inherent monopoly on being allies of science and scientific thinking. So what can scientists do? All politics is local and personal. The majority of Americans say they don’t know a scientist. This is an easy thing to work on. Make sure you introduce yourself to others! Visit your lawmakers and let them know that you are funded by federal money. Politicians are most concerned about their own districts and so if you’re a transplant, you likely have connections to more than one district. Try to build a relationship with him or her by seeing if you could help with anything. Figure out if you can help your local community with anything by serving on committees. Speaking of committees, know what committees your representatives are on. When communicating, think carefully about what words you use. Former U.S. Congressman Bart Gordon opined that he never called it climate  change. Instead, he called it energy independence. While branding may sound like a trivial thing to worry about, targeted story telling is extremely important. We would love for our data to speak for itself but people connect best to stories, especially ones concerning things they can relate to or care about.

If you’re interested in science policy, there are a number of good resources available to get better acquainted. The Engaging Scientists & Engineers in Policy (ESEP) Coalition has a wealth of information and resources on their website (http://science-engage.org/). In fact, they host a local monthly science policy happy hour to network and engage those interested in science policy. If you are interested in learning more about the R&D budget, AAAS has an excellent resource with analyses of federal research and development funding (https://www.aaas.org/program/rd-budget-and-policy-program). There you can also find their data dashboard to look at funding for specific agencies for different periods of time.